Diagnostic Substances Industry

Below are the top small-cap diagnostic substances stocks on the NYSE and NASDAQ in terms of cash. Immucor Inc (NASDAQ: BLUD) had $274.68 million in total cash and no debt for the latest quarter. AMAG Pharmaceuticals Inc (NASDAQ: AMAG) had $238.23 million in total cash and no debt for the latest...

Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of operating margin. The trailing-twelve-month operating margin at Accelr8 Technology Corporation (AMEX: AXK) is 48.31%. AXK's ROE for the same period is 36.57%. The trailing-twelve-month...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Immucor Inc (NASDAQ: BLUD) is $331.47 million. BLUD's operating margin for the same period is 39.64%. The trailing-twelve-month revenue at Neogen...

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Immucor Inc (NASDAQ: BLUD) for the next year ending May, 2012 is $1.23 per share. BLUD's trailing-twelve-month operating margin is 39.07...

Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 59.32%. TRIB's PEG ratio is 1.60. The trailing-twelve-month profit margin at Accelr8 Technology...

Below are the top diagnostic substance stocks on the NYSE and NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech Plc (NASDAQ: TRIB) is 59.32%. TRIB's ROE for the same period is 56.37%. The trailing-twelve-month profit margin at Immucor Inc (NASDAQ: BLUD) is...